4. Conclusion
Enzymes are mainly studied in the pharmaceutical field. Inhibiting the catalysts of pathogenic infectious agents or those of disease-causing, abnormally-functioning organisms is one of the mainstays of drug therapy. Activation of these catalysts is also possible, but much less common in therapy.
To characterize enzyme inhibition and activation, the main experimental technique is kinetic monitoring of the transformation of substrates into products.
The most classical enzymatic kinetics and the modes of action of the main effectors are reviewed. A paragraph devoted to a new type of inhibition, that of oligomerization, opens up future perspectives in the field of enzymology. New modes of action for enzyme inhibitors and activators are then possible.
This new research into new modes of enzyme inhibition is accompanied...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Conclusion
Bibliography
Bibliography
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference